Literature DB >> 7040846

Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis.

R J Havel.   

Abstract

New aspects in the pathogenesis and diagnosis of familial dysbetalipoproteinemia are discussed, including the clarification of the chemical basis of the polymorphism of apoprotein E, the allelic nature of the primary isoforms of the protein, the relationship of the abnormality of apoprotein E to the accumulation of remnant lipoproteins in dysbetalipoproteinemia and in persons carrying the trait for abnormal apoprotein E, and the pathogenesis of hyperlipidemia in this disorder. The related clinical features of dysbetalipoproteinemia are included in the discussion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7040846     DOI: 10.1016/s0025-7125(16)31429-8

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  13 in total

1.  Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

Authors:  H N Ginsberg; N A Le; I J Goldberg; J C Gibson; A Rubinstein; P Wang-Iverson; R Norum; W V Brown
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

Review 2.  Lipid lowering drugs.

Authors:  P O'Connor; J Feely; J Shepherd
Journal:  BMJ       Date:  1990-03-10

3.  Plasma and lipoprotein lipid responses to four hypolipid drugs.

Authors:  W R Hazzard; P W Wahl; C Gagne; D Applebaum-Bowden; G R Warnick; J J Albers
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

Review 4.  Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk.

Authors:  G Thompson
Journal:  Br Heart J       Date:  1984-06

5.  Human noninsulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E.

Authors:  C J Fielding; G M Reaven; P E Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

6.  Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E.

Authors:  T Vogel; K H Weisgraber; M I Zeevi; H Ben-Artzi; A Z Levanon; S C Rall; T L Innerarity; D Y Hui; J M Taylor; D Kanner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia.

Authors:  G Feussner; J Dobmeyer; H J Gröne; S Lohmer; S Wohlfeil
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

8.  Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.

Authors:  R J Havel; L Kotite; J P Kane; P Tun; T Bersot
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

9.  Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.

Authors:  C F Sing; J Davignon
Journal:  Am J Hum Genet       Date:  1985-03       Impact factor: 11.025

10.  Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.

Authors:  C Ehnholm; R W Mahley; D A Chappell; K H Weisgraber; E Ludwig; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.